Physician profile
Maged Azer
NPI 1992730709
$8,887.93
in general payments reported to CMS, 2019-2025
40 companies · $832 in 2025
The $832 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,633 · 2020: $2,089 · 2021: $1,129 · 2022: $969 · 2023: $888 · 2024: $1,348 · 2025: $832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,068.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,765.63 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $1,577.73 | 2019-2025 | |
| Pfizer INC. | $614.34 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $576.58 | 2019-2024 | Jardiance |
| Amgen INC. | $517.91 | 2019-2025 | Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $439.14 | 2019-2024 | |
| Astellas Pharma US INC | $437.10 | 2019-2022 | |
| Cvrx, INC. | $427.69 | 2022-2025 | Barostim Neo System |
| Shockwave Medical, INC | $304.91 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $297.99 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $284.68 | 2019-2025 | Lifevest |
| Edwards Lifesciences Corporation | $244.28 | 2023-2025 | Sapien 3 Ultra Resilia, Evoque, Pascal |
| E.R. Squibb & Sons, L.L.C. | $215.98 | 2021-2025 | Camzyos, Eliquis |
| Genzyme Corporation | $125.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $116.56 | 2019-2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maged Azer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.